| |
|
|
|
Capricor Therapeutics Inc.  
|
|
0.59 0.005 (0.01%) |
03-22 15:59 |
|
Open: |
0.605 |
Pre close: |
0.585 |
Target:
|
0.71
|
|
High: |
0.605 |
Low: |
0.555 |
Resistance:
|
0.61
0.71
|
|
Volume: |
157,148 |
Market Cap: |
18M |
Support:
|
0.49
 0.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.57
|
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
0.50 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
0.61  |
Stochastic Oscillator |
%K(14,3):
|
82.77 |
|
MA(250): |
0.98 |
%D(3): |
83.24 |
|
Average Volume(K) |
3-Month: |
31965
|
52-Week |
High:
|
1.67 |
|
10-Days: |
20929 |
Low: |
0.31 |
|
RSI |
RSI(14):
|
63.47 |
Change(%): |
-61.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.530 |
Return on Equity (ttm) |
27.6 |
Shares Out. (M) |
31.07 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
2.7 |
Shares Float (M) |
27.39 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.30 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-30.0 |
% Held by Institutions |
9.20 |
|
Forward EPS |
-0.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.360 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.09 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.76 |
P/S |
360412000.00 |
|
Operating Margin |
-1020.73 |
Levered Free Cash Flow
(M) |
-8.39 |
P/CF |
-1.41 |
|
|
|
|
|
|
